Pharmaceutical Intermediates Industry Research Report 2024

Pharmaceutical Intermediates Industry Research Report 2024


Summary

Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
According to APO Research, the global Pharmaceutical Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pharmaceutical Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pharmaceutical Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pharmaceutical Intermediates is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pharmaceutical Intermediates include Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF and Porton, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Intermediates.
The report will help the Pharmaceutical Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Pharmaceutical Intermediates segment by Type

GMP
Non-GMP
Pharmaceutical Intermediates segment by Application

Antibiotics
Antipyretic Analgesics
Vitamins
Others
Pharmaceutical Intermediates Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Intermediates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pharmaceutical Intermediates Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pharmaceutical Intermediates Sales (2019-2030)
2.2.3 Global Pharmaceutical Intermediates Market Average Price (2019-2030)
2.3 Pharmaceutical Intermediates by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 GMP
2.3.3 Non-GMP
2.4 Pharmaceutical Intermediates by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Antibiotics
2.4.3 Antipyretic Analgesics
2.4.4 Vitamins
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Pharmaceutical Intermediates Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pharmaceutical Intermediates Sales (K MT) of Manufacturers (2019-2024)
3.3 Global Pharmaceutical Intermediates Revenue of Manufacturers (2019-2024)
3.4 Global Pharmaceutical Intermediates Average Price by Manufacturers (2019-2024)
3.5 Global Pharmaceutical Intermediates Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pharmaceutical Intermediates, Product Type & Application
3.8 Global Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
3.9 Global Pharmaceutical Intermediates Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Lonza
4.1.1 Lonza Company Information
4.1.2 Lonza Business Overview
4.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Lonza Pharmaceutical Intermediates Product Portfolio
4.1.5 Lonza Recent Developments
4.2 Catalent
4.2.1 Catalent Company Information
4.2.2 Catalent Business Overview
4.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Catalent Pharmaceutical Intermediates Product Portfolio
4.2.5 Catalent Recent Developments
4.3 Patheon
4.3.1 Patheon Company Information
4.3.2 Patheon Business Overview
4.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Patheon Pharmaceutical Intermediates Product Portfolio
4.3.5 Patheon Recent Developments
4.4 Jubilant
4.4.1 Jubilant Company Information
4.4.2 Jubilant Business Overview
4.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Jubilant Pharmaceutical Intermediates Product Portfolio
4.4.5 Jubilant Recent Developments
4.5 Granules
4.5.1 Granules Company Information
4.5.2 Granules Business Overview
4.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Granules Pharmaceutical Intermediates Product Portfolio
4.5.5 Granules Recent Developments
4.6 Ganesh
4.6.1 Ganesh Company Information
4.6.2 Ganesh Business Overview
4.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
4.6.5 Ganesh Recent Developments
4.7 Chemcon
4.7.1 Chemcon Company Information
4.7.2 Chemcon Business Overview
4.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Chemcon Pharmaceutical Intermediates Product Portfolio
4.7.5 Chemcon Recent Developments
4.8 BASF
4.8.1 BASF Company Information
4.8.2 BASF Business Overview
4.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.8.4 BASF Pharmaceutical Intermediates Product Portfolio
4.8.5 BASF Recent Developments
4.9 Porton
4.9.1 Porton Company Information
4.9.2 Porton Business Overview
4.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Porton Pharmaceutical Intermediates Product Portfolio
4.9.5 Porton Recent Developments
4.10 Lianhetech
4.10.1 Lianhetech Company Information
4.10.2 Lianhetech Business Overview
4.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
4.10.5 Lianhetech Recent Developments
4.11 ABA Chem
4.11.1 ABA Chem Company Information
4.11.2 ABA Chem Business Overview
4.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.11.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
4.11.5 ABA Chem Recent Developments
4.12 Tianma
4.12.1 Tianma Company Information
4.12.2 Tianma Business Overview
4.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Tianma Pharmaceutical Intermediates Product Portfolio
4.12.5 Tianma Recent Developments
4.13 Jiujiujiu
4.13.1 Jiujiujiu Company Information
4.13.2 Jiujiujiu Business Overview
4.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
4.13.5 Jiujiujiu Recent Developments
4.14 Alpha
4.14.1 Alpha Company Information
4.14.2 Alpha Business Overview
4.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Alpha Pharmaceutical Intermediates Product Portfolio
4.14.5 Alpha Recent Developments
4.15 Jiuzhou
4.15.1 Jiuzhou Company Information
4.15.2 Jiuzhou Business Overview
4.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
4.15.5 Jiuzhou Recent Developments
4.16 Yongtai
4.16.1 Yongtai Company Information
4.16.2 Yongtai Business Overview
4.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Yongtai Pharmaceutical Intermediates Product Portfolio
4.16.5 Yongtai Recent Developments
5 Global Pharmaceutical Intermediates Market Scenario by Region
5.1 Global Pharmaceutical Intermediates Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pharmaceutical Intermediates Sales by Region: 2019-2030
5.2.1 Global Pharmaceutical Intermediates Sales by Region: 2019-2024
5.2.2 Global Pharmaceutical Intermediates Sales by Region: 2025-2030
5.3 Global Pharmaceutical Intermediates Revenue by Region: 2019-2030
5.3.1 Global Pharmaceutical Intermediates Revenue by Region: 2019-2024
5.3.2 Global Pharmaceutical Intermediates Revenue by Region: 2025-2030
5.4 North America Pharmaceutical Intermediates Market Facts & Figures by Country
5.4.1 North America Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pharmaceutical Intermediates Sales by Country (2019-2030)
5.4.3 North America Pharmaceutical Intermediates Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
5.5.1 Europe Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pharmaceutical Intermediates Sales by Country (2019-2030)
5.5.3 Europe Pharmaceutical Intermediates Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Country
5.6.1 Asia Pacific Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pharmaceutical Intermediates Sales by Country (2019-2030)
5.6.3 Asia Pacific Pharmaceutical Intermediates Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
5.7.1 Latin America Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pharmaceutical Intermediates Sales by Country (2019-2030)
5.7.3 Latin America Pharmaceutical Intermediates Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
5.8.1 Middle East and Africa Pharmaceutical Intermediates Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Pharmaceutical Intermediates Sales by Type (2019-2030)
6.1.1 Global Pharmaceutical Intermediates Sales by Type (2019-2030) & (K MT)
6.1.2 Global Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
6.2 Global Pharmaceutical Intermediates Revenue by Type (2019-2030)
6.2.1 Global Pharmaceutical Intermediates Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
6.3 Global Pharmaceutical Intermediates Price by Type (2019-2030)
7 Segment by Application
7.1 Global Pharmaceutical Intermediates Sales by Application (2019-2030)
7.1.1 Global Pharmaceutical Intermediates Sales by Application (2019-2030) & (K MT)
7.1.2 Global Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
7.2 Global Pharmaceutical Intermediates Revenue by Application (2019-2030)
7.2.1 Global Pharmaceutical Intermediates Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
7.3 Global Pharmaceutical Intermediates Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pharmaceutical Intermediates Value Chain Analysis
8.1.1 Pharmaceutical Intermediates Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pharmaceutical Intermediates Production Mode & Process
8.2 Pharmaceutical Intermediates Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pharmaceutical Intermediates Distributors
8.2.3 Pharmaceutical Intermediates Customers
9 Global Pharmaceutical Intermediates Analyzing Market Dynamics
9.1 Pharmaceutical Intermediates Industry Trends
9.2 Pharmaceutical Intermediates Industry Drivers
9.3 Pharmaceutical Intermediates Industry Opportunities and Challenges
9.4 Pharmaceutical Intermediates Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings